1 |
Foerster F, Gairing SJ, Müller L, Galle PR. NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options. J Hepatol 2021:S0168-8278(21)02037-7. [PMID: 34555422 DOI: 10.1016/j.jhep.2021.09.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
Wen S, An R, Li ZG, Lai ZX, Li DL, Cao JX, Chen RH, Zhang WJ, Li QH, Lai XF, Sun SL, Sun LL. Citrus maxima and tea regulate AMPK signaling pathway to retard the progress of nonalcoholic fatty liver disease. Food Nutr Res 2022;66. [PMID: 35757439 DOI: 10.29219/fnr.v66.7652] [Reference Citation Analysis]
|
3 |
Servin F, Collins JA, Heiselman JS, Frederick-dyer KC, Planz VB, Geevarghese SK, Brown DB, Miga MI. Fat Quantification Imaging and Biophysical Modeling for Patient-Specific Forecasting of Microwave Ablation Therapy. Front Physiol 2022;12:820251. [DOI: 10.3389/fphys.2021.820251] [Reference Citation Analysis]
|
4 |
Ore A, Akinloye OA. Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions. Medicina (Kaunas) 2021;57:822. [PMID: 34441028 DOI: 10.3390/medicina57080822] [Reference Citation Analysis]
|